DIABETIC WEIGHT MANAGEMENT

Diabetes Weight Management

Achieve More in Diabetic Weight Management with GLP-1 RA

Expert Endocrine Care

Providing top-notch care to patients with endocrine disorders.

Patient-Centric Approach

Dedicated to providing personalized treatment plans.

Experienced Endocrine Specialists

Achieve optimal health and well-being with guidance.

Book Now

Smiling woman with a weighing scale and measuring tape, promoting diabetes weight management at Cedar Endocrine Clinic.

Progressive weight reduction

Icon of a hand using a glucose meter, representing diabetes management at Cedar Endocrine Clinic in Singapore.

Helps control blood sugar

Lower heart &

kidney disease risk

What is

GLP-1 Receptor Agonists

Close-up of hands holding an insulin pen, illustrating diabetes treatment options at Cedar Endocrine Clinic in Singapore.

GLP-1 receptor agonists (GLP1ra) are approved in Singapore for treating type 2 diabetes and aiding weight loss. They come in various forms, including daily injectables, tablets and weekly injectable, offering similar effects.

How GLP-1 Receptor Agonists Works

GLP-1 receptor agonists (GLP1ra) work by stimulating insulin production, reducing peptide hormone secretion, and slowing stomach emptying. Collectively helping control blood sugar levels and may lead to weight loss in patients with type 2 diabetes.

GLP-1 Receptor Agonists Benefits

Woman jogging outdoors in a green park, representing Cedar Endocrine Clinic’s focus on active lifestyle and fitness for hormone and metabolic health in Singapore.

The benefits of GLP-1 receptor agonists (GLP1ra) include improved blood sugar regulation, lower A1C levels, potential weight reduction, and reduced risk of major cardiovascular events in patients with type 2 diabetes and existing heart disease.

Dr Tay Tunn Lin

SENIOR CONSULTANT ENDOCRINOLOGIST

Dr. Tay Tunn Lin, a Senior Consultant Endocrinologist with 15+ years' experience, specialises in diabetes and thyroid disorders.

Graduating from the National University of Singapore in 2004, she received her post-graduate degree and completed Endocrinology training in 2012.

Dr. Tay is the Director of the Diabetes Centre at Changi General Hospital and a Visiting Consultant. With special expertise in early onset diabetes, she has received accolades for high standards in patient care, aiming to deliver personalised and high-quality care in her private practice.

Over 15 years of Expertise in Endocrinology

Leadership in Diabetes Care since 2015

Dedication to high standards in patient care

1 /10

Adults suffer from diabetes globally

60%

Individuals with diabetes in struggle with weight management

7 Times

Higher risk of heart disease and stroke with uncontrolled diabetes

OUR TREATMENT

Convenient Administration

Weekly injections for ease

Long-Term Effectiveness

Sustains improved blood sugar control

Positive Lipid Impact

Improves blood lipid profiles

Weight Loss Aid

Supports weight reduction

How GLP-1 RA Medications Helps You In Weight Reduction

Slows

Digestion

Teal insulin pens and white tablets, illustrating a 15% weight loss achieved using GLP-1 receptor agonists, a treatment option at Cedar Endocrine Clinic in Singapore.

Reduces

Appetite

Improves Blood Sugar Control

Icon of a hand using a glucose meter, highlighting improved blood sugar control with GLP-1 receptor agonists at Cedar Endocrine Clinic in Singapore.

How long do you stay on GLP-1 Receptor Agonists (GLP1ra) for weight reduction

The duration of GLP-1 Receptor Agonists (GLP1ra) treatment for weight reduction varies depending on individual factors such as weight goals, response to the medication, and overall health status. Typically, treatment with GLP-1 Receptor Agonists (GLP1ra) may continue for several months to a year or longer to achieve sustainable weight reduction. It is essential to follow your healthcare provider's guidance regarding the duration of treatment.
What does GLP-1 Receptor Agonists (GLP1ra) do to the body?

GLP-1 receptor agonists work by mimicking the effects of a naturally occurring peptide hormone. When injected, GLP-1 Receptor Agonists (GLP1ra) stimulate insulin production from the pancreas in response to elevated blood sugar levels. It also reduces the amount of peptide hormone released by the pancreas, which helps lower blood sugar levels. Additionally, GLP-1 Receptor Agonists (GLP1ra) slow down the emptying of the stomach, leading to increased feelings of fullness and reduced food intake. These mechanisms collectively contribute to better blood sugar control and weight management.
What are the side effects of GLP-1 Receptor Agonists (GLP1ra)?

Common side effects of GLP-1 Receptor Agonists (GLP1ra) include gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, and abdominal pain. Other potential side effects may include headaches, decreased appetite, fatigue, dizziness, and injection site reactions. It's essential to report any unusual or severe side effects to your healthcare provider promptly.
Will I gain weight back if I stop using GLP-1 Receptor Agonists (GLP1ra)?

Weight management is multifaceted and involves lifestyle changes such as a healthy diet, regular exercise, and behavior modifications. While GLP-1 Receptor Agonists (GLP1ra) can aid in weight loss, discontinuing the medication alone may lead to weight regain if healthy habits are not maintained. It's crucial to work with your healthcare provider to develop a comprehensive weight management plan that includes sustainable lifestyle changes even after stopping GLP-1 Receptor Agonists (GLP1ra) treatment.